Medtech Funding Cools From Its Peak — But the Brain-Computer Interface Race Heats Up

3 days ago
2 min read

What's New

After a record run, medtech is taking a breather. Venture funding moderated in Q1 2026 following a multiyear high of $16.1 billion in 2025, while PE deal count dropped to 26 — about 41% below the initially reported Q1 2025 level, according to PitchBook's Q1 2026 Medtech VC and PE Trends report. Even so, median deal sizes kept climbing, and a brain-computer interface (BCI) arms race accelerated.

Why It Matters

A funding slowdown paired with rising median check sizes is the signature of a maturing market: fewer deals, but bigger ones concentrated in proven categories like surgical robotics and frontier bets like BCI. Capital is becoming more selective, not absent.

Big Picture Drivers

Off the peak: VC funding cooled from 2025's $16.1B high, reflecting a more disciplined investor stance.
Bigger, fewer PE deals: A 26-deal quarter with rising check sizes points to platform-building over volume.
Surgical robotics liquidity: EdgeMedical's $2.2 billion IPO in January led VC exits.
BCI momentum: Merge Labs entered the fray in January 2026 with a $252 million round, intensifying the brain-computer interface race.

By The Numbers

$16.1B: 2025 medtech VC funding high, the benchmark the quarter cooled from.
26 deals: Q1 2026 PE count, ~41% below initially reported Q1 2025.
$11.8M: Rising median deal size, up toward record territory.
$2.2B: EdgeMedical's surgical-robotics IPO, the quarter's marquee exit.

Key Trends to Watch

BCI buildout: New entrants and large rounds suggest BCI is becoming a defined investment category.
Robotics exits: EdgeMedical's listing could reopen a medtech IPO path if it trades well.
Selectivity: Expect capital to keep concentrating into larger rounds for de-risked assets.

The Wrap

Medtech's quarter reads less like a retreat than a recalibration. Investors pulled back on volume but paid up for category leaders and frontier science — and with surgical robotics finding exit liquidity and BCI heating up, the sector's next chapter looks more concentrated and more ambitious than its record-setting 2025.